143 related articles for article (PubMed ID: 9579563)
1. Tumor-specific peptides in cutaneous T-cell lymphoma: association with class I major histocompatibility complex and possible derivation from the clonotypic T-cell receptor.
Berger CL; Longley BJ; Imaeda S; Christensen I; Heald P; Edelson RL
Int J Cancer; 1998 May; 76(3):304-11. PubMed ID: 9579563
[TBL] [Abstract][Full Text] [Related]
2. The clonotypic T cell receptor is a source of tumor-associated antigens in cutaneous T cell lymphoma.
Berger CL; Longley J; Hanlon D; Girardi M; Edelson R
Ann N Y Acad Sci; 2001 Sep; 941():106-22. PubMed ID: 11594564
[TBL] [Abstract][Full Text] [Related]
3. Definition of TCR epitopes for CTL-mediated attack of cutaneous T cell lymphoma.
Winter D; Fiebiger E; Meraner P; Auer H; Brna C; Strohal R; Trautinger F; Knobler R; Fischer GF; Stingl G; Maurer D
J Immunol; 2003 Sep; 171(5):2714-24. PubMed ID: 12928425
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
5. The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens.
Berger CL; Wang N; Christensen I; Longley J; Heald P; Edelson RL
J Invest Dermatol; 1996 Sep; 107(3):392-7. PubMed ID: 8751976
[TBL] [Abstract][Full Text] [Related]
6. Identification of HLA class I dependent immunogenic peptides from clonotypic TCRbeta expressed in cutaneous T-cell lymphoma.
Zeng J; Müller-Berghaus J; Nguyen XD; Klüter H; Schönhaber H; Song M; Schwinn N; Schadendorf D; Goerdt S; Eichmüller S; Dippel E
Int J Cancer; 2006 Nov; 119(10):2476-80. PubMed ID: 16858680
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas.
Bagot M; Nikolova M; Schirm-Chabanette F; Wechsler J; Boumsell L; Bensussan A
Ann N Y Acad Sci; 2001 Sep; 941():31-8. PubMed ID: 11594580
[TBL] [Abstract][Full Text] [Related]
8. Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.
Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
Int Immunol; 2003 Sep; 15(9):1073-80. PubMed ID: 12917259
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells.
Berger CL; Tigelaar R; Cohen J; Mariwalla K; Trinh J; Wang N; Edelson RL
Blood; 2005 Feb; 105(4):1640-7. PubMed ID: 15514008
[TBL] [Abstract][Full Text] [Related]
10. TNF-mediated toxicity after massive induction of specific CD8+ T cells following immunization of mice with a tumor-specific peptide.
Bilsborough J; Uyttenhove C; Colau D; Bousso P; Libert C; Weynand B; Boon T; van den Eynde BJ
J Immunol; 2002 Sep; 169(6):3053-60. PubMed ID: 12218121
[TBL] [Abstract][Full Text] [Related]
11. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
Jäger E; Karbach J; Gnjatic S; Jäger D; Maeurer M; Atmaca A; Arand M; Skipper J; Stockert E; Chen YT; Old LJ; Knuth A
Cancer Immun; 2002 Sep; 2():12. PubMed ID: 12747757
[TBL] [Abstract][Full Text] [Related]
12. High-scatter T cells: a reliable biomarker for malignant T cells in cutaneous T-cell lymphoma.
Clark RA; Shackelton JB; Watanabe R; Calarese A; Yamanaka K; Campbell JJ; Teague JE; Kuo HP; Hijnen D; Kupper TS
Blood; 2011 Feb; 117(6):1966-76. PubMed ID: 21148332
[TBL] [Abstract][Full Text] [Related]
13. Enhanced expression of T-cell activation and natural killer cell antigens indicates systemic anti-tumor response in early primary cutaneous T-cell lymphoma.
Asadullah K; Friedrich M; Döcke WD; Jahn S; Volk HD; Sterry W
J Invest Dermatol; 1997 May; 108(5):743-7. PubMed ID: 9129226
[TBL] [Abstract][Full Text] [Related]
14. Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes.
Nguyen T; Naziruddin B; Dintzis S; Doherty GM; Mohanakumar T
Int J Cancer; 1999 May; 81(4):607-15. PubMed ID: 10225452
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinaselike 5 is a novel target of immunotherapy in adult T-cell leukemia.
Kawahara M; Hori T; Matsubara Y; Okawa K; Uchiyama T
J Immunother; 2007; 30(5):499-505. PubMed ID: 17589290
[TBL] [Abstract][Full Text] [Related]
16. Dramatic influence of V beta gene polymorphism on an antigen-specific CD8+ T cell response in vivo.
Bour H; Michielin O; Bousso P; Cerottini JC; MacDonald HR
J Immunol; 1999 Apr; 162(8):4647-56. PubMed ID: 10202004
[TBL] [Abstract][Full Text] [Related]
17. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination.
Zang YC; Hong J; Rivera VM; Killian J; Zhang JZ
J Immunol; 2000 Apr; 164(8):4011-7. PubMed ID: 10754292
[TBL] [Abstract][Full Text] [Related]
18. Isolation of a CD8alphaalpha+ CD4- tumour T-cell clone with cytotoxic activity from a CD4+ CD8- cutaneous T-cell lymphoma.
Nikolova M; Echchakir H; Wechsler J; Boumsell L; Bensussan A; Bagot M
Br J Dermatol; 2003 Jan; 148(1):24-9. PubMed ID: 12534590
[TBL] [Abstract][Full Text] [Related]
19. Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line.
Waanders GA; Rimoldi D; Liénard D; Carrel S; Lejeune F; Dietrich PY; Cerottini JC; Romero P
Clin Cancer Res; 1997 May; 3(5):685-96. PubMed ID: 9815737
[TBL] [Abstract][Full Text] [Related]
20. Increased percentage of CD8+CD28- suppressor lymphocytes in peripheral blood and skin infiltrates correlates with advanced disease in patients with cutaneous T-cell lymphomas.
Urbaniak-Kujda D; Kapelko-Słowik K; Wołowiec D; Dybko J; Hałoń A; Jaźwiec B; Maj J; Jankowska-Konsur A; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2009 Jul; 63():355-9. PubMed ID: 19644152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
